$868 Million is the total value of KINGDON CAPITAL MANAGEMENT, L.L.C.'s 72 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BAC | BANK AMERICA CORPcall | $13,690,000 | -4.6% | 500,000 | 0.0% | 1.58% | +16.4% | |
| ROG | ROGERS CORP | $10,215,219 | -18.8% | 77,700 | 0.0% | 1.18% | -1.0% | |
| PRAX | PRAXIS PRECISION MEDICINES I | $8,892,000 | +48.7% | 5,200,000 | 0.0% | 1.02% | +81.2% | |
| WNS | WNS HLDGS LTDspon adr | $5,476,800 | -7.1% | 80,000 | 0.0% | 0.63% | +13.3% | |
| XAIR | BEYOND AIR INC | $3,149,828 | -45.8% | 1,363,562 | 0.0% | 0.36% | -33.9% | |
| GEG | GREAT ELM GROUP INC | $2,951,165 | +4.4% | 1,379,049 | 0.0% | 0.34% | +27.3% | |
| XFOR | X4 PHARMACEUTICALS INC | $2,151,314 | -43.8% | 1,973,683 | 0.0% | 0.25% | -31.5% | |
| JASPER THERAPEUTICS INC | $2,128,000 | -48.9% | 3,040,000 | 0.0% | 0.24% | -37.7% | ||
| ENVVENO MEDICAL CORPORATION | $1,181,380 | +75.0% | 219,180 | 0.0% | 0.14% | +112.5% | ||
| NIOCORP DEVS LTD | $1,141,508 | -27.8% | 314,465 | 0.0% | 0.13% | -12.1% | ||
| VINC | VINCERX PHARMA INC | $388,850 | -22.3% | 385,000 | 0.0% | 0.04% | -4.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FLEXION THERAPEUTICS INC | 30 | Q2 2021 | 3.1% |
| SPDR S&P 500 ETF TR | 29 | Q3 2023 | 34.8% |
| ISHARES TR | 27 | Q3 2023 | 13.2% |
| HERON THERAPEUTICS INC | 23 | Q3 2019 | 4.2% |
| SOL GEL TECHNOLOGIES | 23 | Q3 2023 | 1.5% |
| META PLATFORMS INC | 22 | Q3 2023 | 5.9% |
| LIBERTY MEDIA CORP | 21 | Q4 2018 | 1.4% |
| NOMAD HLDGS LTD | 19 | Q3 2020 | 2.1% |
| AMAZON COM INC | 18 | Q3 2022 | 7.6% |
| SPDR SER TR | 18 | Q3 2023 | 5.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Praxis Precision Medicines, Inc. | January 25, 2023 | 2,855,989 | 6.1% |
| GTY Technology Holdings Inc. | February 10, 2020 | 1,598,212 | 3.1% |
| Jaguar Health, Inc. | February 10, 2020 | 270 | 0.0% |
| Sesen Bio, Inc. | February 10, 2020 | 4,040,835 | 3.9% |
| Eleven Biotherapeutics, Inc. | April 04, 2018 | 2,213,980 | 5.1% |
| AIT Therapeutics, Inc. | April 02, 2018 | 400,859 | 4.8% |
| FATE THERAPEUTICS INCSold out | February 14, 2018 | 0 | 0.0% |
| Great Elm Capital Group, Inc. | February 14, 2018 | 1,267,030 | 5.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2018 | 2,179,620 | 3.4% |
| Horizon Pharma plcSold out | February 14, 2018 | 0 | 0.0% |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-04-15 |
| 13F-HR/A | 2024-03-18 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2024-02-06 |
| SC 13G/A | 2023-11-29 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
View KINGDON CAPITAL MANAGEMENT, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.